OneAscent Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History

OneAscent Financial Services’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$211K	Sell	425 -28	-6%	-$12.4K	0.01%	574
2026 Q1	$202K	Buy	+453	New	+$211K	0.01%	569
2024 Q2	–	Sell	-704	Closed	-$294K	–	398
2024 Q1	$294K	Sell	704 -49	-7%	-$20.7K	0.03%	295
2023 Q4	$306K	Sell	753 -234	-24%	-$86.4K	0.04%	262
2023 Q3	$343K	Sell	987 -17	-2%	-$5.95K	0.09%	166
2023 Q2	$353K	Buy	1,004 +119	+13%	+$40.1K	0.16%	72
2023 Q1	$279K	Sell	885 -167	-16%	-$50.1K	0.11%	122
2022 Q4	$304K	Buy	1,052 +9	+0.9%	+$2.74K	0.13%	111
2022 Q3	$302K	Sell	1,043 -429	-29%	-$123K	0.12%	118
2022 Q2	$415K	Buy	1,472 +505	+52%	+$135K	0.19%	93
2022 Q1	$252K	Buy	+967	New	+$229K	0.18%	98
2021 Q1	–	Sell	-1,040	Closed	-$246K	–	162
2020 Q4	$246K	Sell	1,040 -940	-47%	-$216K	0.26%	94
2020 Q3	$539K	Buy	+1,980	New	+$546K	0.28%	66

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

OneAscent Financial Services's VRTX Position: Q2 2026 in Review

OneAscent Financial Services reduced its Vertex Pharmaceuticals (VRTX) stake by 6.2% in Q2 2026, selling an estimated $12.4K and leaving 425 shares worth $211K. The position accounts for 0.01% of the portfolio, ranked #574.

OneAscent Financial Services first reported a position in VRTX in Q3 2020 and has held it in 13 quarters since. The position peaked at $539K in Q3 2020. 1,747 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

OneAscent Financial Services held 425 shares of Vertex Pharmaceuticals worth $211K as of Q2 2026.
OneAscent Financial Services sold 28 Vertex Pharmaceuticals shares in Q2 2026, an estimated $12.4K.
Vertex Pharmaceuticals made up 0.01% of OneAscent Financial Services's portfolio in Q2 2026, its #574 holding.
OneAscent Financial Services first reported a position in Vertex Pharmaceuticals in Q3 2020 and has held it in 13 quarters since.
OneAscent Financial Services's Vertex Pharmaceuticals position peaked at $539K in Q3 2020.
1,747 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on OneAscent Financial Services's 13F filing for Q2 2026, filed 11 Aug 2026.